Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126659911 | 12665991 | 1 | I | 201607 | 20160812 | 20160818 | 20160818 | EXP | US-ASTRAZENECA-2016SE87448 | ASTRAZENECA | 892.00 | MON | F | Y | 86.20000 | KG | 20160819 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126659911 | 12665991 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 19810 | 40 | MG | CAPSULE | QD | |||||||
| 126659911 | 12665991 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 19810 | 40 | MG | CAPSULE | QD | |||||||
| 126659911 | 12665991 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 19810 | 40 | MG | CAPSULE | QD | |||||||
| 126659911 | 12665991 | 4 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | Y | U | 0 | TABLET | ||||||||
| 126659911 | 12665991 | 5 | SS | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 1.5 | DF | TABLET | BID | |||||||
| 126659911 | 12665991 | 6 | SS | LOPERAMIDE HCL | LOPERAMIDE HYDROCHLORIDE | 1 | Oral | 2.0MG AS REQUIRED | Y | U | P94425 | 0 | 2 | MG | |||||
| 126659911 | 12665991 | 7 | SS | TIKOSYN | DOFETILIDE | 1 | Oral | 974 | MG | 0 | .25 | MG | CAPSULE | Q12H | |||||
| 126659911 | 12665991 | 8 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | 100 | UG | TABLET | QD | |||||||
| 126659911 | 12665991 | 9 | C | LIVALO | PITAVASTATIN CALCIUM | 1 | Oral | 0 | 4 | MG | TABLET | QD | |||||||
| 126659911 | 12665991 | 10 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 0 | 400 | MG | TABLET | QD | |||||||
| 126659911 | 12665991 | 11 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 0 | 400 | MG | TABLET | QD | |||||||
| 126659911 | 12665991 | 12 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 0 | 400 | MG | TABLET | BID | |||||||
| 126659911 | 12665991 | 13 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 0 | 400 | MG | TABLET | BID | |||||||
| 126659911 | 12665991 | 14 | C | CALCIUM 600+VITAMIN D 400 | 2 | Oral | 0 | 1 | DF | TABLET | QD | ||||||||
| 126659911 | 12665991 | 15 | C | CALCIUM 600+VITAMIN D 400 | 2 | Oral | 0 | 1 | DF | TABLET | QD | ||||||||
| 126659911 | 12665991 | 16 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 126659911 | 12665991 | 17 | C | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 0 | 150 | MG | CAPSULE | BID | |||||||
| 126659911 | 12665991 | 18 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 0 | 25 | MG | TABLET | QD | |||||||
| 126659911 | 12665991 | 19 | C | MECLAZINE | 2 | Oral | 25.0MG AS REQUIRED | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126659911 | 12665991 | 1 | Gastrooesophageal reflux disease |
| 126659911 | 12665991 | 2 | Gastrooesophageal reflux disease |
| 126659911 | 12665991 | 3 | Polyp |
| 126659911 | 12665991 | 4 | Blood cholesterol abnormal |
| 126659911 | 12665991 | 5 | Arrhythmia |
| 126659911 | 12665991 | 6 | Diarrhoea |
| 126659911 | 12665991 | 7 | Atrial fibrillation |
| 126659911 | 12665991 | 8 | Thyroid disorder |
| 126659911 | 12665991 | 9 | Blood triglycerides increased |
| 126659911 | 12665991 | 10 | Blood magnesium decreased |
| 126659911 | 12665991 | 11 | Atrial fibrillation |
| 126659911 | 12665991 | 12 | Blood magnesium decreased |
| 126659911 | 12665991 | 13 | Atrial fibrillation |
| 126659911 | 12665991 | 14 | Mastectomy |
| 126659911 | 12665991 | 15 | Radiotherapy |
| 126659911 | 12665991 | 16 | Cardiac failure congestive |
| 126659911 | 12665991 | 17 | Prophylaxis |
| 126659911 | 12665991 | 18 | Diuretic therapy |
| 126659911 | 12665991 | 19 | Vertigo |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126659911 | 12665991 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126659911 | 12665991 | Atrial fibrillation | |
| 126659911 | 12665991 | Diarrhoea | |
| 126659911 | 12665991 | Dizziness | |
| 126659911 | 12665991 | Drug ineffective | |
| 126659911 | 12665991 | Muscle spasms | |
| 126659911 | 12665991 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126659911 | 12665991 | 6 | 20160804 | 0 | ||
| 126659911 | 12665991 | 7 | 201103 | 0 | ||
| 126659911 | 12665991 | 9 | 2016 | 0 | ||
| 126659911 | 12665991 | 14 | 2007 | 0 | ||
| 126659911 | 12665991 | 15 | 2007 | 0 | ||
| 126659911 | 12665991 | 16 | 2011 | 0 | ||
| 126659911 | 12665991 | 17 | 2011 | 0 |